Skip to main content

New Aspirin Guide Mobile app helping clinicians and patients... both

New Aspirin-Guide mobile app helps clinicians and patients make informed decisions about aspirin use

Posted in: Device / Technology News | Medical Research News | Medical Condition News | Pharmaceutical News

Published on June 21, 2016 at 12:15 PM

Low dose aspirin is recommended by clinicians as a preventive measure for patients who have already had a heart attack or stroke, but the risk of taking low-dose aspirin to prevent or delay a first heart attack or stroke is less clear, as the benefit for reducing the risk of cardiovascular disease (CVD) must be balanced with the increased risk of gastrointestinal or other bleeding. To help clinicians and patients make informed decisions about aspirin use, researchers at Brigham and Women's Hospital have developed a new, free, mobile app, "Aspirin-Guide" that calculates both the CVD risk score and the bleeding risk score for the individual patient, and helps clinicians decide which patients are appropriate candidates for the use of low-dose aspirin (75 to 81 mg daily).

"We developed the Aspirin-Guide app because we realized that weighing the risks and benefits of aspirin for individuals who have not had a heart attack or stroke is a complex process. The new mobile app enables individualized benefit to risk assessment in a matter of seconds while the patient is with the physician," said Samia Mora, MD, cardiologist at BWH.

In a commentary published in JAMA in the June 20 issue, and a review in JAMA Internal Medicine published on the same day, co-authors Mora, and JoAnn Manson, MD, cardiovascular epidemiologist and Chief of Preventive Medicine at BWH, review the evidence behind the use of aspirin to delay or prevent a first heart attack of stroke, and give examples of how the mobile app can help patients and clinicians including:

•calculates a 10-year cardiovascular disease risk score (heart disease and stroke) for the patient
•calculates a bleeding risk score based on the patient's individual risk factors
•uses evidence from the literature, together with the above scores, to compare the number needed to treat vs. the number needed to harm
•helps clinicians to implement current clinical guidelines for low-dose aspirin in primary prevention
•provides the ability to email a summary of the decision-making process to the patient and/or to the clinician for the patient's record.

"Aspirin-Guide is a user-friendly clinical decision support tool, that will facilitate informed and personalized decision-making about the use of aspirin in primary prevention of CVD. Patients should discuss the pros and cons of aspirin treatment with their healthcare provider," Manson said.

Source: Brigham and Women’s Hospital

Comments

Post a Comment

Popular posts from this blog

Post a Comment
Read more

Monoclonal Antibody Targets, Kills Leukemia Cells

Monoclonal Antibody Targets, Kills Leukemia Cells  Researchers at the University of California, San Diego Moores Cancer Center have identified a humanized monoclonal antibody that targets and directly kills chronic lymphocytic leukemia (CLL) cells The findings, published in the online Early Edition of the Proceedings of the National Academy of Sciences on March 25, 2013 represent a potential new therapy for treating at least some patients with CLL, the most common type of blood cancer in the United States. CLL cells express high levels of a cell-surface glycoprotein receptor called CD44. Principal investigator Thomas Kipps, MD, PhD, Evelyn and Edwin Tasch Chair in Cancer Research, and colleagues identified a monoclonal antibody called RG7356 that specifically targeted CD44 and was directly toxic to cancer cells, but had little effect on normal B cells. Moreover, they found RG7356 induced CLL cells that expressed the protein ZAP-70 to undergo apoptosis or programmed cell dea...
1 comment
Read more

Natural killer cell = The wonder creation , may be a mutation of WBC......

Natural killer cell From Wikipedia, the free encyclopedia   (Redirected from Natural Killer cell ) Jump to: navigation , search Natural killer cells (or NK cells ) are a type of cytotoxic lymphocyte critical to the innate immune system . The role NK cells play is analogous to that of cytotoxic T cells in the vertebrate adaptive immune response . NK cells provide rapid responses to virally infected cells and respond to tumor formation, acting at around 3 days after infection . Typically immune cells detect MHC presented on infected cell surfaces, triggering cytokine release causing lysis or apoptosis . NK cells are unique, however, as they have the ability to recognize stressed cells in the absence of antibodies and MHC, allowing for a much faster immune reaction. They were named “natural killers” because of the initial notion that they do not require activation in order...
Post a Comment
Read more